Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.

Pastore, M R; Bazzigaluppi, E; Bonfanti, R; Dozio, N; Sergi, A; Balini, A; Belloni, C; Meschi, F; Bonifacio, E; Bosi, E

Pastore, M R; Bazzigaluppi, E; Bonfanti, R; Dozio, N; Sergi, A; Balini, A; Belloni, C; Meschi, F; Bonifacio, E; Bosi, E.

Affiliation

Pastore MR; Department of Internal Medicine, Istituto Scientifico Ospedale San Raffaele, University of Milan, Italy.

Diabetes Care ; 21(9): 1445-50, 1998 Sep.

Article in En | MEDLINE | ID: mdl-9727889

Subject(s)

Autoantibodies/analysis; Diabetes Mellitus, Type 1/diagnosis; Islets of Langerhans/immunology; Adult; Biomarkers; Diabetes Mellitus, Type 1/epidemiology; Diabetes Mellitus, Type 1/genetics; Family; Glutamate Decarboxylase/immunology; Humans; Insulin/immunology; Prevalence; Risk Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Islets of Langerhans / Diabetes Mellitus, Type 1 Type of study: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Humans Language: En Journal: Diabetes Care Year: 1998 Document type: Article

Search on Google

XML

PubMed Links